• VOLOCIXIMAB chembl:CHEMBL2108061 Antineoplastic

    Alternate Names:

    M-200
    VOLOCIXIMAB
    M200

    Drug Info:

    Drug Class monoclonal antibody
    Drug Indications antineoplastic agent
    FDA Approval not approved
    (2 More Sources)

    Publications:

  • Interaction Score: 9.11

    Interaction Types & Directionality:
    antibody (inhibitory)
    antagonist (inhibitory)

    Interaction Info:
    Mechanism of Interaction Integrin alpha-5/beta-1 antagonist
    Direct Interaction yes
    Details of the Assay for Interaction Binding affinity to human α5β1-Fc, determined using BIAcore SPR technology.

    PMIDs:
    None found


  • Interaction Score: 7.09

    Interaction Types & Directionality:
    antibody (inhibitory)
    antagonist (inhibitory)

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Integrin alpha-5/beta-1 antagonist
    Notes Targets ALPHA-5/BETA-1 INTEGRIN

    PMIDs:
    None found


  • Interaction Score: 2.13

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Established target
    Trial Name volociximab, E10030, Eos200-4

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

    • Version: January-2014

    Alternate Names:

    Drug Info:
    FDA Approval not approved
    Drug Indications antineoplastic agent
    Drug Class monoclonal antibody

    Publications:

    • Version: 12-May-2016

    Alternate Names:
    M200 Drug Synonym
    VOLOCIXIMAB Drug Generic Name
    VOLOCIXIMAB Primary Drug Name

    Drug Info:

    Publications:

    • Version: 29-September-2020

    Alternate Names:
    VOLOCIXIMAB GuideToPharmacology Ligand Name

    Drug Info:

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D06PVA TTD Drug ID

    Drug Info:

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: